ACE2 and type 2 diabetes mellitus: One of the frequently cited articles about COVID-19 proposes that people with CVD, type 2 diabetes mellitus, hypertension, or, those treated with ACE2 enhancing medications, are at larger hazard for intensive SARS-COV2 putridity and thus must be managed for ACE2-modulating drugs, including ACE inhibitors and angiotensin II type-I receptor blockers (ARBs) (28).